China’s Clinical Trial Capacity Matches US And Draws Global Pharma Interest

China’s Clinical Trial Capacity Matches US And Draws Global Pharma Interest

  • January 7, 2026

China’s rapid rise in clinical research is reshaping the global pharmaceutical landscape. With its current clinical trial capacity now comparable to that of the United States, the country is increasingly viewed as a prime destination for cutting edge drug development, international collaboration and

China’s 3SBio Seeks US$400 Million In Hong Kong To Expand Its Global Drug Pipeline

China’s 3SBio Seeks US$400 Million In Hong Kong To Expand Its Global Drug Pipeline

  • December 2, 2025

Chinese biopharmaceutical company 3SBio has launched a major fundraising effort as it aims to strengthen its drug development pipeline and expand its global footprint. The Shenyang-based firm announced plans to raise HK$3.12 billion, or roughly US$401 million, through a new share placement in